ask="N/A"
ask_size="N/A"
average_daily_volume="1108450"
bid="37.80"
bid_size="100"
book_value="4.05"
change="-2.43"
change_from_200_day_moving_average="-8.18"
change_from_50_day_moving_average="-2.64"
change_from_52_week_high="-16.31"
change_From_52_week_low="7.59"
change_in_percent="-5.89%"
close="38.84"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.84"
ex_dividend_date="N/A"
float_shares="85794000"
high="41.57"
high_52_weeks="55.15"
last_trade_date="1/23/2017"
last_trade_price="38.84"
last_trade_size="42840"
last_trade_time="4:00pm"
low="38.77"
low_52_weeks="31.25"
market_capitalization="3.37B"
moving_average_200_day="47.02"
moving_average_50_day="41.48"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="41.27"
pe_ratio="N/A"
peg_ratio="0.70"
percent_change_from_200_day_moving_average="-17.40%"
percent_change_from_50_day_moving_average="-6.37%"
percent_change_from_52_week_high="-29.57%"
percent_change_from_52_week_low="+24.29%"
previous_close="41.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.20"
price_per_sales="239.01"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.55"
stock_exchange="NMS"
symbol="NBIX"
volume="1083543"
weeks_range_52="31.25 - 55.15"
